A maternal vaccine against group B Streptococcus

Group B Streptococcus (GBS) is a major cause of morbidity and mortality among neonates. Though there have been tremendous advances in prevention of invasive neonatal GBS disease through prophylactic antibiotic treatment of pregnant women, the incidence of neonatal disease has not changed significantly over the past several years. Vaccination of pregnant women is an important strategy that has the potential to improve further on existing protocols. In this review, we explore the history of the design of maternal GBS vaccines. Chen et all. discussed recent applications of genomics and immunology to vaccine.


Haber: Dr.Ümit Savaşçı

Posted September 11, 2013